{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T18:06:53Z","timestamp":1776794813028,"version":"3.51.2"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.saa.2022.122074","type":"journal-article","created":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T16:28:51Z","timestamp":1670257731000},"page":"122074","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["New ecological first derivative synchronous spectrofluorimetric method for simultaneous quantification of carvedilol and ivabradine in tablets"],"prefix":"10.1016","volume":"289","author":[{"given":"Ethar A.","family":"Rashad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samar S.","family":"Elsayed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenny Jeehan M.","family":"Nasr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fawzia A.","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.saa.2022.122074_b0005","first-page":"630","article-title":"Development of validated RP-HPLC method for simultaneous estimation of carvedilol and ivabradine","volume":"4","author":"Patel","year":"2015","journal-title":"World J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.saa.2022.122074_b0010","unstructured":"British Pharmacopeia. Vol. 1. Medicines and Health care products Regulatory Agency, Medicinal substances, 2016."},{"key":"10.1016\/j.saa.2022.122074_b0015","article-title":"Simple methods for the spectrophotometric determination of carvedilol","volume":"2012","author":"Shetty","year":"2012","journal-title":"Int. Scholarly Res. Notices"},{"key":"10.1016\/j.saa.2022.122074_b0020","first-page":"34","article-title":"Spectrophotometric determination of carvedilol in pharmaceutical formulations through charge-transfer and ion-pair complexation reactions","volume":"62","author":"Cardoso","year":"2007","journal-title":"Die Pharmazie-Int. J. Pharm. Sci."},{"key":"10.1016\/j.saa.2022.122074_b0025","first-page":"956","article-title":"Development of UV spectrophotometric method for estimation of carvedilol in bulk and pharmaceutical formulations","volume":"6","author":"Manohar","year":"2013","journal-title":"Asian J. Res. Chem."},{"key":"10.1016\/j.saa.2022.122074_b0030","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1365\/s10337-005-0656-y","article-title":"Determination of carvedilol and its impurities in pharmaceuticals","volume":"62","author":"Stojanovi\u0107","year":"2005","journal-title":"Chromatographia"},{"key":"10.1016\/j.saa.2022.122074_b0035","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1007\/s10337-013-2537-0","article-title":"Validated stability-indicating HPLC\u2013DAD determination of the antihypertensive binary mixture of carvedilol and hydrochlorothiazide in tablet dosage forms","volume":"76","author":"Belal","year":"2013","journal-title":"Chromatographia"},{"key":"10.1016\/j.saa.2022.122074_b0040","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2174\/1573412913666170525122146","article-title":"Development and validation of a stability-indicating HPLC method for the assay of carvedilol in pure and tablet dosage forms","volume":"14","author":"Ahmed","year":"2018","journal-title":"Curr. Pharm. Anal."},{"key":"10.1016\/j.saa.2022.122074_b0045","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1080\/10826070701224937","article-title":"New RP-HPLC Method with UV-Detection for the Determination of Carvedilol in Human Serum","volume":"30","author":"Gannu","year":"2007","journal-title":"J. Liq. Chromatogr. Relat. Technol."},{"key":"10.1016\/j.saa.2022.122074_b0050","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jchromb.2007.07.021","article-title":"Estimation of carvedilol in human plasma by using HPLC-fluorescence detector and its application to pharmacokinetic study","volume":"857","author":"Rathod","year":"2007","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.saa.2022.122074_b0055","doi-asserted-by":"crossref","first-page":"790","DOI":"10.4103\/0250-474X.31017","article-title":"RP-HPLC and HPTLC methods for the estimation of carvedilol in bulk drug and pharmaceutical formulations","volume":"68","author":"Patel","year":"2006","journal-title":"Indian J. Pharm. Sci."},{"key":"10.1016\/j.saa.2022.122074_b0060","first-page":"2231","article-title":"Simple and accurate RP-HPLC and TLC-Densitometric methods for determination of carvedilol in pharmaceutical formulations","volume":"2","author":"Abdel-Gawad","year":"2012","journal-title":"Int. J. Res. Pharm. Chem"},{"key":"10.1016\/j.saa.2022.122074_b0065","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1556\/1326.2017.00367","volume":"30","author":"Nguyen","year":"2018","journal-title":"Acta Chromatogr."},{"key":"10.1016\/j.saa.2022.122074_b0070","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/chrsci\/49.1.35","article-title":"Determination of carvedilol in human plasma by gas chromatography-mass spectrometry method","volume":"49","author":"Yilmaz","year":"2011","journal-title":"J. Chromatogr. Sci."},{"key":"10.1016\/j.saa.2022.122074_b0075","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1080\/14779072.2018.1489235","article-title":"Role of ivabradine and heart rate lowering in chronic heart failure: guideline update","volume":"16","author":"Chow","year":"2018","journal-title":"Expert Rev. Cardiovasc. Ther."},{"key":"10.1016\/j.saa.2022.122074_b0080","first-page":"56","article-title":"Corlanor (ivabradine), first HCN channel blocker FDA approved for the treatment of patients with heart failure","volume":"9","author":"Fala","year":"2016","journal-title":"American Health Drug Benefits"},{"key":"10.1016\/j.saa.2022.122074_b0085","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/bio.4187","article-title":"Micellar-emphasized simultaneous determination of ivabradine hydrochloride and felodipine using synchronous spectrofluorimetry","volume":"37","author":"Yosrey","year":"2022","journal-title":"Luminescence"},{"key":"10.1016\/j.saa.2022.122074_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.saa.2021.120330","article-title":"Fluorescence spectroscopy method for estimation of Ivabradine in bulk and the tablet dosage form","volume":"264","author":"Tailor","year":"2022","journal-title":"Spectrochim. Acta A Mol. Biomol. Spectrosc."},{"key":"10.1016\/j.saa.2022.122074_b0095","doi-asserted-by":"crossref","DOI":"10.1002\/bio.4337","article-title":"First derivative synchronous spectrofluorimetric analysis of bisoprolol fumarate and ivabradine in pharmaceutical and biological matrices. Investigation of the method greenness","author":"Abo Elkheir","year":"2022","journal-title":"Luminescence"},{"key":"10.1016\/j.saa.2022.122074_b0100","doi-asserted-by":"crossref","unstructured":"R. Abo Shabana, H. Elmansi, F. Ibrahim, Utility of synchronous fluorimetry for the concurrent quantitation of metoprolol and ivabradine, Spectrochim. Acta Part A: Mol. Biomol. Spectroscopy 280 (2022) 121482.","DOI":"10.1016\/j.saa.2022.121482"},{"key":"10.1016\/j.saa.2022.122074_b0105","first-page":"024","article-title":"Determination of ivabradine in rat plasma by a validated HPLC with fluorescence detection","volume":"4","author":"Cui","year":"2010","journal-title":"Chin. Pharm. J."},{"key":"10.1016\/j.saa.2022.122074_b0110","first-page":"53","article-title":"Quantitative determination and validation of ivabradine HCl by stability indicating RP-HPLC method and spectrophotometric method in solid dosage form","volume":"5","author":"Maheshwari","year":"2010","journal-title":"Eurasian J. Anal. Chem."},{"key":"10.1016\/j.saa.2022.122074_b0115","doi-asserted-by":"crossref","first-page":"228","DOI":"10.25004\/IJPSDR.2017.090505","article-title":"Validated rp-hplc method for the determination of ivabradine hydrochloride in pharmaceutical formulation","volume":"9","author":"Muzaffar-ur-Rehman","year":"2017","journal-title":"Int. J. Pharm. Sci. Drug Res"},{"key":"10.1016\/j.saa.2022.122074_b0120","doi-asserted-by":"crossref","first-page":"667","DOI":"10.4103\/0250-474X.78545","article-title":"Development and validation of RP-HPLC method for the estimation of ivabradine hydrochloride in tablets","volume":"72","author":"Seerapu","year":"2010","journal-title":"Indian J. Pharm. Sci."},{"key":"10.1016\/j.saa.2022.122074_b0125","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1080\/22297928.2017.11952555","article-title":"Stability indicating spectrophotometric methods for determination of Ivabradine hydrochloride in the presence of its degradation product","volume":"7","author":"Mostafa","year":"2017","journal-title":"Analy. Chem. Lett."},{"key":"10.1016\/j.saa.2022.122074_b0130","first-page":"141","article-title":"Development and validation of stability-indicating HPTLC method for ivabradine HCl","volume":"6","author":"Damle","year":"2015","journal-title":"Pharm Sci Monitor"},{"key":"10.1016\/j.saa.2022.122074_b0135","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.bfopcu.2013.07.001","article-title":"Validated stability-indicating high performance thin layer chromatographic method for determination of Ivabradine hydrochloride in bulk and marketed formulation: an application to kinetic study","volume":"51","author":"Motisariya","year":"2013","journal-title":"Bull. Faculty Pharm., Cairo University"},{"key":"10.1016\/j.saa.2022.122074_b0140","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jfda.2013.05.006","article-title":"Chromatographic analysis of ivabradine on polar, nonpolar and chemically modified adsorbents by HPTLC","volume":"21","author":"Pikul","year":"2013","journal-title":"J. Food Drug Anal."},{"key":"10.1016\/j.saa.2022.122074_b0145","first-page":"321","article-title":"Three spectrophotometric approaches for measuring ratio spectra of Ivabradine and Carvedilol in a binary mixture using green analytical principles, Current","volume":"11","author":"Chanduluru","year":"2022","journal-title":"Chem. Lett."},{"key":"10.1016\/j.saa.2022.122074_b0150","article-title":"Screening Design and Response Surface Methodology for the Simultaneous Estimation of Carvedilol and Ivabradine HCl by HPTLC Method","author":"Prajapati","year":"2021","journal-title":"J. Chromatogr. Sci."},{"key":"10.1016\/j.saa.2022.122074_b0155","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1080\/10826076.2018.1427595","article-title":"Development and validation of UPLC method for simultaneous quantification of carvedilol and ivabradine in the presence of degradation products using DoE concept","volume":"41","author":"Nadella","year":"2018","journal-title":"J. Liq. Chromatogr. Relat. Technol."},{"key":"10.1016\/j.saa.2022.122074_b0160","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ijcard.2011.06.098","article-title":"Effect of Carvedilol, Ivabradine or their combination on exercise capacity in patients with Heart Failure the CARVIVA HF trial","volume":"151","author":"Volterrani","year":"2011","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.saa.2022.122074_b0165","unstructured":"ICH Harmonised Tripartite guidelines,validation of analytical procedure:text and methodology Q2(R1), https:\/\/www.ich.org\/page\/quality-guidelines."},{"key":"10.1016\/j.saa.2022.122074_b0170","series-title":"Statistics and chemometrics for analytical chemistry","author":"Miller","year":"2018"},{"key":"10.1016\/j.saa.2022.122074_b0175","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1021\/cr068359e","article-title":"Green analytical methodologies","volume":"107","author":"Keith","year":"2007","journal-title":"Chem. Rev."},{"key":"10.1016\/j.saa.2022.122074_b0180","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.talanta.2018.01.013","article-title":"A new tool for the evaluation of the analytical procedure: Green Analytical Procedure Index","volume":"181","author":"P\u0142otka-Wasylka","year":"2018","journal-title":"Talanta"},{"key":"10.1016\/j.saa.2022.122074_b0185","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.trac.2012.03.013","article-title":"Analytical Eco-Scale for assessing the greenness of analytical procedures","volume":"37","author":"Ga\u0142uszka","year":"2012","journal-title":"TrAC Trends Anal. Chem."},{"key":"10.1016\/j.saa.2022.122074_b0190","doi-asserted-by":"crossref","first-page":"10076","DOI":"10.1021\/acs.analchem.0c01887","article-title":"AGREE\u2014Analytical GREEnness metric approach and software","volume":"92","author":"Pena-Pereira","year":"2020","journal-title":"Anal. Chem."}],"container-title":["Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386142522012227?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386142522012227?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T02:21:13Z","timestamp":1761358873000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386142522012227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":38,"alternative-id":["S1386142522012227"],"URL":"https:\/\/doi.org\/10.1016\/j.saa.2022.122074","relation":{},"ISSN":["1386-1425"],"issn-type":[{"value":"1386-1425","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New ecological first derivative synchronous spectrofluorimetric method for simultaneous quantification of carvedilol and ivabradine in tablets","name":"articletitle","label":"Article Title"},{"value":"Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.saa.2022.122074","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"122074"}}